Fundraising Fox
Rho Bio
1 known investors
Find your way into Rho Bio
741 people in our graph can introduce you to the Rho Bio team.
Sign up to see every warm intro you have to Rho Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rho Bio team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rho Bio is a biotechnology company focused on lymphatic flow, developing therapeutics related to the lymphatic system.
Founders & leadership
JB
Jennifer BeechamPresident, Co-FounderJennifer Beecham is co-founder and president of Rho Bio, a biotechnology company developing therapeutics for the lymphatic system. She previously held finance, strategy, and commercial roles at Reata Pharmaceuticals and worked in algorithmic trading at Barclays, and holds a Master's degree in Bioengineering with four years of radiation oncology research experience.
ES
Eric SongScientific FounderHis research background centers on immune mechanisms in the brain and eye.
AR
Aaron RingScientific Founder
JK
Jonathan KipnisScientific Founder
AI
Akiko IwasakiScientific Founder
Investors · 1
Related companies · 4
RhoRho offers a business savings account that spreads idle cash across 400+ FDIC-insured banks (via American Deposit Management) for up to $75M in deposit coverage and yield. It is part of Rho's financial platform for founders and finance teams that combines checking, savings, treasury, spending, bill pay, and accounting.
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Rallybio, LLCRallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology. It draws on its team's experience across drug discovery, research, development, manufacturing, and regulatory strategy to advance rare-disease drug candidates.
Ori BiotechOri Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
Companies working in the same space as Rho Bio.
Frequently asked questions
- What does Rho Bio do?
- Rho Bio is a biotechnology company focused on lymphatic flow, developing therapeutics related to the lymphatic system.
- Who founded Rho Bio?
- Rho Bio was founded by Jennifer Beecham, Eric Song, Aaron Ring, Jonathan Kipnis, Akiko Iwasaki.
- Who are Rho Bio's investors?
- Rho Bio's investors include Connecticut Innovations.